Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time Interval Between Glaucoma Eye Drops
NCT03220490Unknown
- Sponsor
- Sheba Medical Center
- Start
- Nov 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of brimonidine and timolol in Glaucoma (4 arms), sponsored by Sheba Medical Center. Primary endpoints: Difference in Intraocular Pressure Reduction at 6 hours and Change in Intraocular Pressure at 1 month. Status: unknown.
02
Drugs
brimonidinetimolol
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT03220490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03220490.